These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6668515)

  • 21. Bone marrow morphology during induction phase of therapy for acute myeloid leukemia (AML).
    Dick FR; Burns CP; Weiner GJ; Heckman KD
    Hematol Pathol; 1995; 9(2):95-106. PubMed ID: 7559259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leukemic infiltration of the testes in acute nonlymphocytic leukemia.
    Wagner VM; Baehner RL
    Med Pediatr Oncol; 1984; 12(3):166-8. PubMed ID: 6727774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensive maintenance therapy improves survival in adult acute nonlymphocytic leukemia: an eight-year follow-up.
    Dutcher JP; Wiernik PH; Markus S; Weinberg V; Schiffer CA; Harwood KV
    Leukemia; 1988 Jul; 2(7):413-9. PubMed ID: 3393023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitoxantrone and cytosine arabinoside (ARA-C) in adult acute leukemia: an interim report.
    Kansu E; Koc Y; Kars A; Alakavuklar M; Tekuzman G; Firat D
    J Chemother; 1989 Jul; 1(4 Suppl):1268-70. PubMed ID: 16312861
    [No Abstract]   [Full Text] [Related]  

  • 25. De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study.
    Hasserjian RP; Campigotto F; Klepeis V; Fu B; Wang SA; Bueso-Ramos C; Cascio MJ; Rogers HJ; Hsi ED; Soderquist C; Bagg A; Yan J; Ochs R; Orazi A; Moore F; Mahmoud A; George TI; Foucar K; Odem J; Booth C; Morice W; DeAngelo DJ; Steensma D; Stone RM; Neuberg D; Arber DA
    Am J Hematol; 2014 Nov; 89(11):E193-9. PubMed ID: 25042343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic resonance imaging of the bone marrow in patients with acute leukemia during and after chemotherapy. Changes in T1 relaxation.
    Jensen KE; Grundtvig Sørensen P; Thomsen C; Christoffersen P; Henriksen O; Karle H
    Acta Radiol; 1990 Jul; 31(4):361-9. PubMed ID: 2206692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Reversal of myelofibrosis is an important pre-transplant factor for bone marrow grafting--a successful case of allogeneic bone marrow transplantation for an acute megakaryoblastic leukemia].
    Masauzi N; Tanaka J; Ohizumi H; Kiyama Y; Naohara T; Higa T; Kasai M; Imamura M; Miyazaki T
    Rinsho Ketsueki; 1994 Feb; 35(2):148-53. PubMed ID: 8139112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical application of thymidine kinase activity in patients with acute non-lymphocytic leukemia].
    Sampi K; Takagi T; Sakai C; Kuraishi Y; Ishige K
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):69-73. PubMed ID: 1987902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysmegakaryopoiesis predicting response to therapy in acute myeloid leukaemia. A histologic and clinical study.
    Delacrétaz F; Spertini O; Schmidt PM; Grob JP
    Pathol Res Pract; 1991 Mar; 187(2-3):290-5. PubMed ID: 2068013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transplantation of patients with high risk acute myeloid leukemia in first remission with autologous marrow cultured in interleukin-2 followed by interleukin-2 administration.
    Klingemann HG; Eaves CJ; Barnett MJ; Eaves AC; Hogge DE; Nantel SH; Reece E; Shepherd JD; Sutherland HJ; Phillips GL
    Bone Marrow Transplant; 1994 Sep; 14(3):389-96. PubMed ID: 7994260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary excretion of proteolyzed alpha1-antitrypsin: specificity, quantitation, and relation to therapy response in patients with acute myeloid leukemia.
    Dengler R; Plewan A; Münstermann U; Busch R; Eger G; Emmerich B
    Clin Cancer Res; 1995 Feb; 1(2):199-205. PubMed ID: 9815974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. All-trans retinoic acid and low-dose cytosine arabinoside for the treatment of 'poor prognosis' acute myeloid leukemia.
    Venditti A; Stasi R; Del Poeta G; Buccisano F; Aronica G; Bruno A; Pisani F; Caravita T; Masi M; Tribalto M
    Leukemia; 1995 Jul; 9(7):1121-5. PubMed ID: 7630182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose-escalation trial of M195 labeled with iodine 131 for cytoreduction and marrow ablation in relapsed or refractory myeloid leukemias.
    Schwartz MA; Lovett DR; Redner A; Finn RD; Graham MC; Divgi CR; Dantis L; Gee TS; Andreeff M; Old LJ
    J Clin Oncol; 1993 Feb; 11(2):294-303. PubMed ID: 8426207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Timed-sequential chemotherapy with concomitant granulocyte colony-stimulating factor for newly diagnosed de novo acute myelogenous leukemia.
    He XY; Pohlman B; Lichtin A; Rybicki L; Kalaycio M
    Leukemia; 2003 Jun; 17(6):1078-84. PubMed ID: 12764371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A characteristic pattern of leukemic cell differentiation without cytoreduction during remission induction in acute promyelocytic leukemia.
    Kantarjian HM; Keating MJ; McCredie KB; Beran M; Walters R; Dalton WT; Hittleman W; Freireich EJ
    J Clin Oncol; 1985 Jun; 3(6):793-8. PubMed ID: 3859586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A histopathological study of bone marrow following chemotherapy of acute myeloid leukemia].
    Pu Q
    Zhonghua Yi Xue Za Zhi; 1991 Aug; 71(8):431-3, 30. PubMed ID: 1660761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evolution of acute leukemia in myelodysplastic syndromes: prognostic histopathological factors in a series of bone marrow biopsies].
    Navone R; Ranco V; Pich A
    Pathologica; 1991; 83(1083):55-63. PubMed ID: 1866200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A method comparison study of flow cytometry and cytomorphology to determine the percentages of blasts in patients with acute leukemia after induction and consolidation chemotherapy.
    Wongprajun S; Auewarakul CU
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S157-64. PubMed ID: 20364570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral idarubicin in combination with cytosine-arabinoside in previously untreated patients with acute non-lymphocytic leukemia.
    Falkson G; Coccia-Portugal MA; Vorobiof DA; Terblanche AP; Dreyer R
    Am J Clin Oncol; 1986 Aug; 9(4):311-4. PubMed ID: 3463190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Early evaluation of therapeutic response in acute lymphoblastic leukaemia. A study of cytoreduction in blood and bone marrow (author's transl)].
    Marie JP; David B; Tulliez M; Diebold J; Zittoun R
    Nouv Presse Med; 1982 Feb; 11(7):505-7. PubMed ID: 6950363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.